As Dietas Hospitalares

[pic 1]

HOSPITAL Dr. PEDRO GARCIA MORENO FILHO FICHA DE ACOMPANHAMENTO NUTRICIONAL EM UTI

Identificação do Nutricionista

NOME DO PACIENTE

DATA DE ADM.:        /        /

ID(a):

P (Kg):

AJ (Cm):

CB (cm):

CPan (cm):

Alt (m):

IMC(Kg/m2):

DIAGNÓSTICO NUTRICIONAL:

CAL/Kg:

NEE:

VOLUME (mL/dia):

META DA VZ:

Ptn:

DIAGNÓSTICO CLÍNICO:

BOX:_______

DIA DA SEM

DIA DA SEM

DIA DA SEM

DIA DA SEM

DIA DA SEM

DATA

DATA

DATA

DATA

DATA

DIETA

VAZÃO

HORA/DIETA

POSIÇÃO

DISPOSITIVOS

INTERAÇÃO

EUPNEICO

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

ANICTÉRICO

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

ACIANÓTICO

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

EDEMA

(I)

(I)

(S)

(S)

(I)

(I)

(S)

(S)

(I)

(I)

(S)

(S)

(I)

(I)

(S)

(S)

(I)

(I)

(S)

(S)

ABDOMEN

G

P

E

OUTRO

G

P

E

OUTRO

G

P

E

OUTRO

G

P

E

OUTRO

G

P

E

OUTRO

DIURESE

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

SVD/VOL

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

DEJEÇÕES

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

EMÊSE

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

FEBRIL

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

(S)

(N)

GLICEMIA

PA/ PA MÉDIA

MEDICAÇÕES VASOATIVAS

NORADRELINA

NITROPRUSSIATO

NITROGLICERINA

DOPAMINA

DOBUTAMINA

MEDICAÇÕES SEDATIVAS

MIDAZOLAN

FENTANIL

QUETAMINA

PROPOFOL

PRECEDEX

POTÁSSIO

3,7–5,6 mEq/L

3,7–5,6 mEq/L

3,7–5,6 mEq/L

3,7–5,6 mEq/L

3,7–5,6 mEq/L

UREIA

15–45 mg/dL

15–45 mg/dL

15–45 mg/dL

15–45 mg/dL

15–45 mg/dL

FÓSFORO

2,5–4,5 g/dL

2,5–4,5 g/dL

2,5–4,5 g/dL

2,5–4,5 g/dL

2,5–4,5 g/dL

SÓDIO

136–145 mEq/L

136–145 mEq/L

136–145 mEq/L

136–145 mEq/L

136–145 mEq/L

CLORO

96-109 mEq/lL

96-109 mEq/lL

96-109 mEq/lL

96-109 mEq/lL

96-109 mEq/lL

MAGNÉSIO

1,58-2,56 mg/dL

1,58-2,56 mg/

1,58-2,56 mg/

1,58-2,56 mg/

1,58-2,56 mg/

LACTATO VENOS

4,5-19,8 mg/dL

4,5-19,8mg/dL

4,5-19,8mg/dL

4,5-19,8mg/dL

4,5-19,8mg/dL

CREATININA

M

0,7–1,2 mg/dL

0,7–1,2 mg/dL

0,7–1,2 mg/dL

0,7–1,2 mg/dL

0,7–1,2 mg/dL

F

0,5-1,0 mg/dL

0,5-1,0 mg/dL

0,5-1,0 mg/dL

0,5-1,0 mg/dL

0,5-1,0 mg/dL

Erit.

(M)

4,3-6,0M/mm3

4,3-6,0M/mm3

4,3-6,0M/mm3

4,3-6,0M/mm3

4,3-6,0M/mm3

(F)

3,9-5,3 M/mm3

3,9-5,3 M/mm3

3,9-5,3 M/mm3

3,9-5,3 M/mm3

3,9-5,3 M/mm3

Hb.

(M)

14–17 g/dL

14–17 g/dL

14–17 g/dL

14–17 g/dL

14–17 g/dL

(F)

12-16 g/dL

12-16 g/dL

12-16 g/dL

12-16 g/dL

12-16 g/dL

Htc.

(M)

41–51%

41–51%

41–51%

41–51%

41–51%

(F)

36-48%

36-48%

36-48%

36-48%

36-48%

PLAQUETAS

150-400 X 109/L

150-400 X 109/L

150-400 X 109/L

150-400 X 109/L

150-400 X 109/L

LEUCÓCITOS

3,6–11 x 103 células/mcL

4,5–11 x 103 células/mcL

4,5–11 x 103 células/mcL

4,5–11 x 103 células/mcL

4,5–11 x 103 células/mcL

OUTRO

BALANÇO H.

(+)

(-)

(+)

(-)

(+)

(-)

(+)

(-)

(+)

(-)

EVOLUÇÃO:_________________________________________________________________________________________________ _____________________________________________________________________________________________________________ _____________________________________________________________________________________________________________ _____________________________________________________________________________________________________________ _____________________________________________________________________________________________________________ _____________________________________________________________________________________________________________

FICHA DE ACOMPANHAMENTO NUTRICIONAL EM UTI-HRI. V6.0 (08/12/2021)

...